With immediate effect, Robert Coury is back as Mylan executive chairman, a move that positions the former company head closer to CEO Heather Bresch and president Rajiv Malik as Mylan looks to close its protracted merger with Pfizer’s Upjohn unit and navigate its way through the accelerating COVID-19 pandemic.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?